Galectin Therapeutics
GALT
#8074
Rank
C$0.23 B
Marketcap
$3.73
Share price
1.48%
Change (1 day)
42.95%
Change (1 year)

Galectin Therapeutics (GALT) - Cash on Hand

Cash on Hand as of June 2024 : C$34.72 M

According to Galectin Therapeutics's latest financial reports the company has C$34.72 M in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Galectin Therapeutics - Cash on Hand chart (from 2001 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31C$25.22 M-49.72%
2021-12-31C$50.17 M44.97%
2020-12-31C$34.61 M-43.77%
2019-12-31C$61.55 M446.71%
2018-12-31C$11.25 M193.31%
2017-12-31C$3.83 M-81.41%
2016-12-31C$20.64 M-42.48%
2015-12-31C$35.89 M6.24%
2014-12-31C$33.78 M202.75%
2013-12-31C$11.15 M19.57%
2012-12-31C$9.33 M43.42%
2011-12-31C$6.5 M10.35%
2010-12-31C$5.89 M2129.99%
2009-12-31C$0.26 M-31.95%
2008-12-31C$0.38 M-69.95%
2007-12-31C$1.29 M-80.76%
2006-12-31C$6.72 M29.27%
2005-12-31C$5.19 M-55.48%
2004-12-31C$11.67 M17.11%
2003-12-31C$9.97 M228.66%
2002-12-31C$3.03 M27.74%
2001-12-31C$2.37 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$1.32 B 3,714.49%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.33 B 867.89%๐Ÿ‡บ๐Ÿ‡ธ USA